Antimicrobial peptides´ immune modulation role in intracellular bacterial infection

Front Immunol. 2023 Mar 28:14:1119574. doi: 10.3389/fimmu.2023.1119574. eCollection 2023.

Abstract

Intracellular bacteria cause a wide range of diseases, and their intracellular lifestyle makes infections difficult to resolve. Furthermore, standard therapy antibiotics are often unable to eliminate the infection because they have poor cellular uptake and do not reach the concentrations needed to kill bacteria. In this context, antimicrobial peptides (AMPs) are a promising therapeutic approach. AMPs are short cationic peptides. They are essential components of the innate immune response and important candidates for therapy due to their bactericidal properties and ability to modulate host immune responses. AMPs control infections through their diverse immunomodulatory effects stimulating and/or boosting immune responses. This review focuses on AMPs described to treat intracellular bacterial infections and the known immune mechanisms they influence.

Keywords: antimicrobial peptides; cell-penetrating peptides; host defense peptides; immunomodulation; intracellular bacterial infection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Cationic Peptides
  • Antimicrobial Peptides*
  • Bacteria
  • Bacterial Infections* / drug therapy
  • Bacterial Infections* / microbiology
  • Humans
  • Immunity, Innate

Substances

  • Antimicrobial Peptides
  • Antimicrobial Cationic Peptides
  • Anti-Bacterial Agents